Dr. Saleh Alqahtani is Director of Clinical Liver Research and Medical Director of International Digestive and Liver Disease Services at the Division of Gastroenterology and Hepatology at The Johns Hopkins Hospital. A highly regarded expert in liver and digestive diseases, endoscopy, and liver transplant, Dr. Alqahtani has been the principal investigator for clinical trials related to the management of fatty liver disease and viral hepatitis including novel agents. He also is the co-investigator for numerous clinical trials in liver cancer, liver cirrhosis, and outcome of liver transplantation. The recipient of several awards and honors, Dr. Alqahtani has been an invited speaker both nationally and internationally, lecturing in Latin America, Asia, and Europe and has authored many publications and book chapters. Board Certified in transplant hepatology, gastroenterology, and internal medicine, Dr. Alqahtani is a member of professional societies including the American College of Gastroenterology, the Mayo Clinic Alumni Association, the American Association for the Study of Liver Diseases, the European Association for the Study of the Liver, and The Johns Hopkins Medical & Surgical Association. Before coming to Johns Hopkins, Dr. Alqahtani served as Associate Director of the Gastroenterology Fellowship Program at the University of Texas Southwestern Medical Center in Dallas, Texas. He also was an Instructor in Medicine at the Mayo Clinic in Rochester, Minnesota. Dr. Alqahtani earned his medical degree at King Abdulaziz University in Saudi Arabia, completed an internal medicine residency program at University of Western, performed a gastroenterology fellowship at the University of Calgary, and completed an advanced Liver diseases fellowship at the Mayo Clinic, Rochester, Minnesota.

Drug Induced Liver Injury; Liver Cancer; Hepatitis B; Hepatitis C; Fatty Liver Disease